Axitinib, sold under the brand name Inlyta, is a small molecule tyrosine kinase inhibitor developed by Pfizer. It has been shown to significantly inhibit growth of breast cancer in animal models [4] and has shown partial responses in clinical trials with renal cell carcinoma (RCC) [5] and several other tumour types. [6]

INLYTA (axitinib) is a prescription medicine used to treat kidney cancer that has spread or cannot be removed by surgery (advanced renal cell carcinoma or RCC): in combination with pembrolizumab as your first treatment

Sep 27, 2024 · Axitinib is used to treat advanced kidney cancer. Axitinib is sometimes given after at least one other cancer treatment did not work or has stopped working. Axitinib may also be used for purposes not listed in this medication guide.

Axitinib is an antineoplastic agent (cancer medicine). It interferes with the growth of cancer cells, which are eventually destroyed. This medicine is available only with your doctor's prescription.

Axitinib is used in combination with avelumab (Bavencio) or pembrolizumab (Keytruda) to treat advanced renal cell carcinoma. Axitinib is in a class of medications called kinase inhibitors. It works by blocking the action of an abnormal protein that signals cancer cells to multiply.

Axitinib is approved to treat: Renal cell carcinoma (a type of kidney cancer) that is advanced. It is used: With avelumab or pembrolizumab as the first treatment. Alone in patients whose cancer did not get better after one treatment with systemic therapy.

Axitinib works by slowing or stopping the growth of cancer cells. It belongs to a class of drugs known as tyrosine kinase inhibitors. HOW TO USE: Read the Patient Information Leaflet if...

Find patient medical information for axitinib oral on WebMD including its uses, side effects and safety, interactions, pictures, warnings and user ratings.

Axitinib is a type of cancer growth blocker called a tyrosine kinase inhibitor (TKI). Tyrosine kinase inhibitors work by blocking certain proteins (called tyrosine kinases) from acting on cells. Tyrosine kinases signal to cancer cells to grow.

Axitinib (Inlyta ®) is a targeted therapy drug used to treat a type of kidney cancer called renal cell carcinoma that has spread outside of the kidney. This is called advanced or metastatic kidney cancer.